![](/img/cover-not-exists.png)
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies
Burger, Jan A., Cramer, Paula, Barr, Paul M., Dilhuydy, Marie-Sarah, Mato, Anthony, Byrd, John C., Chang, Stephen, Graef, Thorsten, Lin, Tony, Tedeschi, AlessandraLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15784
Date:
February, 2019
File:
PDF, 189 KB
english, 2019